2Brattstrom L, Lindgren A, Israelsson B, et al. Hyperhomocys- teinaemia in stroke : prevalence, cause, and relationships to type of stroke and stroke risk factors[J]. Eur J Clin Invest, 1992, 22:214-216.
3Hankey GJ. Is homocysteine a modifiable risk factor for stroke [J]. Nat Clin Prac Neuro,1 2006,2(1):26-33.
4Kelly PJ, Rosand J, Kistler JP, et al. Homocysteine, MTHFR677C-T polymorphism, and risk of ischemic stroke:results of a meta-analysis[J]. Neurology, 2002 : 59 (4) : 529-536.
7McCully KS. Vascular pathology of homosysteinemia: Implica- tions for the pathogenesis of arteriosclerosi s[J]. Am J pahol, 1969,56(1) :111-128.
8Toole JF, Malinow MR,Chambless LE,et al. Lowening homo- cysteine in patients with ischemic stroke to prevent recurrent stroke,myocardial infaction, and death: the Vitamin Interven- tionfor Stroke Pervention (VISP) randomized conteolled trial [J]. JAMA,2001,291 :565-575.
9Wang X, Qin X,Demirtas H,et al. Efficacy of folic acid supple- mentation in stroke prevention: a meta-analysis[J]. Lancet, 2007,369:1 876-1 882.
10Naghavi M,Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient., a call for new definitions and risk assess- ment strategies : part-I[J]. Circulation, 2003,108 : 1 664-1 672.
5Jeffrey S. Berger,Maria C. Roncaglioni,Fausto Avanzini,Ierta Pangrazzi,Gianni Tognoni,David L. Brown,崔艳丽（译）,赵秀丽（校）.阿斯匹林在男性和女性心血管事件一级预防中的应用——随机对照试验性别特异性汇总分析[J].美国医学会杂志（中文版）,2006,25(5):275-282. 被引量：40
7McCully KS. Vascular pathology of homosysteinemia: Implica- tions for the Pathogenesis of arteriosclerosis[J]. Am J pahol, 1969, 56(1): 111-128.
8Konecky N, Malinow MR, Tunick PA, et al. Correlation between plasma homocysteine and aortic atherosclemasis[J]. Am Heart J, 1997,133(5): 524-540.
9Greham TM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease: The European Coneetred Action Projection[J]. JAMA, 1997, 277(22): 1 775-1 781.
10Refsum H, Ueland PM, Nygardo, et al. Homosysteine and cardio-vascular diseases[J]. Annue Revmed, 1998, 49 : 31.
